Pellegrino P, Falvella F S, Perrone V, Carnovale C, Brusadelli T, Pozzi M, Antoniazzi S, Cheli S, Perrotta C, Clementi E, Radice S
Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco, Italy.
Pharmacogenomics J. 2015 Jun;15(3):284-7. doi: 10.1038/tpj.2014.57. Epub 2014 Oct 7.
Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.
到目前为止,接种相同疫苗的个体中出现不良反应一直被归因于不可预测的随机过程。药物基因组学的最新进展表明,宿主对免疫反应的某些特征受遗传特性影响,因此是可预测的。预测疫苗不良反应的能力将是迈向个性化疫苗学发展的重要一步,并可增强公众对疫苗安全性的信心。在此,我们综述了关于基因变异与健康受试者发生不良反应风险之间关联的所有现有信息。